Rocket Pharmaceuticals (RCKT)
(Delayed Data from NSDQ)
$17.12 USD
-1.35 (-7.31%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $17.13 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-0.77 | 0.00% |
Earnings Summary
For their last quarter, Rocket Pharmaceuticals (RCKT) reported earnings of -$0.74 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for RCKT's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$0.77 per share, reflecting a year-over-year decrease of 2.67%.
Earnings History
Price & Consensus
Zacks News for RCKT
Rocket Stock Down More Than 30% in Past Six Months: Here's Why
RCKT: What are Zacks experts saying now?
Zacks Private Portfolio Services